MedTrace Logo

Evaluation of the Drug-drug Interaction Between Ticagrelor and Venlafaxine When Taken Together in Healthy Volunteers

NCT01350921 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2012-03-30

No results posted yet for this study

Summary

Study evaluates the drug-drug interaction between Ticagrelor and Venlafaxine when taken together in healthy volunteers

Conditions

  • Drug Drug Interaction

Interventions

DRUG

Ticagrelor

90 mg oral immediate release tablets, single dose on days 1 and 9

DRUG

Venlaflaxin

37.5 mg oral immediate release tablets, administered twice daily on days 4-8

Sponsors & Collaborators

Principal Investigators

  • Jay Horrow, PhD · AstraZeneca Wilmington

  • Mirjana Kujacic, PhD · AstraZeneca Mölndal

  • Kelli Craven, MD · Quintiles Kansas Overland Park US

Study Design

Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • United States
  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01350921 on ClinicalTrials.gov